S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
BioXcel Therapeutics Inc (BTAI)
BioXcel Therapeutics Inc (BTAI) Financials

BioXcel Therapeutics Inc (BTAI)

0.47

-0.039

(-7.66%)

Closed November 26 3:00PM

Delayed by 15 minutes

0.4807

0.0107

(2.28%)

After Hours: 6:12PM

Delayed by 15 minutes

BioXcel Therapeutics Inc Financial Summary

The current BTAI market cap is 20.55M. The company's latest EPS is USD -4.1885 and P/E is -0.11.

Income Statement

Annual Quarterly

Quarter End	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	457k	341k	376k	582k	1.1M
Operating Income	-52.41M	-48.3M	-19.88M	-24.16M	-17.3M
Net Income	-53.52M	-50.49M	-22.26M	-26.79M	-8.3M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	0	0	0	375k	1.38M
Operating Income	-33.6M	-82.3M	-106.94M	-159.65M	-171.78M
Net Income	-32.97M	-82.17M	-106.93M	-165.76M	-179.05M

Balance Sheet

Annual Quarterly

Quarter End	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Assets	140.1M	100.45M	73.7M	82.32M	65.44M
Total Liabilities	134.23M	141.06M	130.21M	154.69M	139.74M
Total Equity	5.86M	-40.61M	-56.51M	-72.36M	-74.3M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Assets	36.39M	219.94M	239.44M	205.85M	73.7M
Total Liabilities	9.5M	13.24M	17.77M	129.08M	130.21M
Total Equity	26.9M	206.7M	221.67M	76.78M	-56.51M

Cash Flow

Annual Quarterly

Quarter End	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Operating	-90.56M	-128.14M	-155.01M	-17.71M	-40.88M
Investing	-20k	-20k	-20k	N/A	N/A
Financing	24.4M	24.4M	26.52M	26.63M	31.93M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Operating	-27.28M	-66.35M	-82.15M	-135.34M	-155.01M
Investing	-870k	-316k	-445k	-139k	-20k
Financing	18.01M	247.36M	102.45M	96.24M	26.52M

Stats and Ratios

Market Cap	20.55M
Price to Earnings Ratio	-0.11
Price to Sales Ratio	14.55
Price to Cash Ratio	0.31
Price to Book Ratio	-0.36
Dividend Yield	-

Share Statistics

Shares Outstanding	42.75M
Average Volume (1 week)	590.31k
Average Volume (1 Month)	537.09k
52 Week Change	-87.83%
52 Week High	4.17
52 Week Low	0.49
Spread (Intraday)	0.01 (2.45%)

Company Info

Company Name	BioXcel Therapeutics Inc
Address	251 little falls drive wilmington, delaware 19808
Website	https://www.bioxceltherapeutics.com
Industry	pharmaceutical preparations (2834)

BioXcel Therapeutics

Amagis Dynamic Alloc Tot...

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions